Budget 2016: Vaccine research relief

Vaccine research relief was introduced in 2003 as an additional research and development tax relief for companies. The relief is available only for large companies, and is claimed by less than ten companies a year.

Vaccine research relief will expire for expenditure incurred on or after 1 April 2017.

The take up of this relief is low, so the Government has decided to withdraw the relief with effect from 1 April 2017.